Correlation between the NGF levels and questionnaire forms in patients receiving antimuscarinic treatment and those receiving onabotulinum toxin-A injection.
Süleyman SağırOmer BayrakHaluk SenSeval KulMehmet Sakıp Erturhanİlker SeçkinerPublished in: Turkish journal of urology (2020)
NGF level might be a good marker to evaluate effectiveness of treatment in patients receiving antimuscarinics, owing to correlation of urinary NGF levels with symptom scores. Lack of correlation in patients receiving onaBoNT-A injection could be a result of differences in the mechanism of action.